Literature DB >> 26102436

IMPROVED SPECIFICITY OF POLYPOIDAL CHOROIDAL VASCULOPATHY DIAGNOSIS USING A MODIFIED EVEREST CRITERIA.

Chui Ming Gemmy Cheung1, Augustinus Laude, Wanling Wong, Ranjana Mathur, Choi Mun Chan, Edmund Wong, Doric Wong, Tien Yin Wong, Tock Han Lim.   

Abstract

PURPOSE: To evaluate the performance of polypoidal choroidal vasculopathy (PCV) diagnosis using fundus camera-based indocyanine green angiography, comparing a single sign of "subretinal focal hyperfluorescence" on indocyanine green angiography with a modification of the EVEREST criteria.
METHODS: Color fundus photograph, flash fundus camera-based fluorescein angiography, and indocyanine green angiography of 241 eyes of 230 consecutive patients with exudative maculopathy due to PCV or typical age-related macular degeneration were graded independently by 2 retinal specialists using a modified EVEREST criteria, which requires the presence of subretinal focal hyperfluorescence plus any 1 of 5 additional criteria. Discordant cases were adjudicated by a senior retinal specialist to arrive at the final diagnosis. Sensitivity, specificity, and area under the receiver operating curve of subretinal focal hyperfluorescence versus the EVEREST criteria and combinations of individual EVEREST criteria were compared.
RESULTS: Among the 241 eyes with exudative maculopathy, 131 eyes had PCV and 110 eyes had typical age-related macular degeneration. Using a single sign of subretinal focal hyperfluorescence alone for the diagnosis of PCV, sensitivity was 85.3% and specificity was 80.9%, with an area under the receiver operating curve of 83.1%. When applying the EVEREST definition, sensitivity was reduced to 78.4% but specificity improved to 87.1% with a similar area under the receiver operating curve of 82.8%. The frequency of individual criteria was highly variable, with stereo nodular appearance (73.7%) and orange nodule (55.0%) being the most common and branching vascular network, massive hemorrhage, and hypofluorescent halo in the presence of subretinal focal hyperfluorescence being less common (21.5%-28.1%).
CONCLUSION: The EVEREST criteria have a higher specificity for the diagnosis of PCV than subretinal focal hyperfluorescence alone and may be applied to flash fundus camera-based indocyanine green angiography in a clinical setting. Stereo nodular appearance is the most important additional criterion.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26102436     DOI: 10.1097/IAE.0000000000000482

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  15 in total

1.  Comparison between non-visualized polyps and visualized polyps on optical coherence tomography angiography in polypoidal choroidal vasculopathy.

Authors:  Zongyi Zhan; Limei Sun; Chenjin Jin; Yu Yang; Andina Hu; Miao Tang; Zhirong Wang; Xiaoyan Ding
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-08-24       Impact factor: 3.117

2.  Efficacy and Safety of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: A Randomized Clinical Trial.

Authors:  Adrian Koh; Timothy Y Y Lai; Kanji Takahashi; Tien Y Wong; Lee-Jen Chen; Paisan Ruamviboonsuk; Colin S Tan; Chrystel Feller; Philippe Margaron; Tock H Lim; Won Ki Lee
Journal:  JAMA Ophthalmol       Date:  2017-11-01       Impact factor: 7.389

3.  Small dome-shaped pigment epithelium detachment in polypoidal choroidal vasculopathy: an under-recognized sign of polypoidal lesions on optical coherence tomography?

Authors:  Yuwei Wang; Qiyu Bo; Huixun Jia; Mengsha Sun; Yang Yu; Peirong Huang; Jing Wang; Nana Xu; Fenghua Wang; Hong Wang; Xiaodong Sun
Journal:  Eye (Lond)       Date:  2021-04-08       Impact factor: 3.775

4.  Choroidal Remodeling in Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy: A 12-month Prospective Study.

Authors:  Daniel Shu Wei Ting; Yasuo Yanagi; Rupesh Agrawal; Hwei Yee Teo; Sophia Seen; Ian Yew San Yeo; Ranjana Mathur; Choi Mun Chan; Shu Yen Lee; Edmund Yick Mun Wong; Doric Wong; Tien Yin Wong; Gemmy Chui Ming Cheung
Journal:  Sci Rep       Date:  2017-08-11       Impact factor: 4.379

5.  Management of recalcitrant polypoidal choroidal vasculopathy by feeder vessel laser photocoagulation.

Authors:  Jay Sheth; Giridhar Anantharaman; Shruti Chandra; Mahesh Gopalakrishnan
Journal:  Am J Ophthalmol Case Rep       Date:  2018-01-31

6.  Characteristics and racial variations of polypoidal choroidal vasculopathy in tertiary centers in the United States and United Kingdom.

Authors:  Tarek Alasil; Nelida Munoz; Pearse A Keane; Adnan Tufail; Patrick A Coady; Eduardo Novais; Talisa E de Carlo; Caroline R Baumal; Nadia K Waheed; Jay S Duker; Ron A Adelman
Journal:  Int J Retina Vitreous       Date:  2017-04-17

Review 7.  Polypoidal choroidal vasculopathy: Pearls in diagnosis and management.

Authors:  Giridhar Anantharaman; Jay Sheth; Muna Bhende; Raja Narayanan; Sundaram Natarajan; Anand Rajendran; George Manayath; Parveen Sen; Rupak Biswas; Alay Banker; Charu Gupta
Journal:  Indian J Ophthalmol       Date:  2018-07       Impact factor: 1.848

8.  Characterizing Branching Vascular Network Morphology in Polypoidal Choroidal Vasculopathy by Optical Coherence Tomography Angiography.

Authors:  Chu-Hsuan Huang; Po-Ting Yeh; Yi-Ting Hsieh; Tzyy-Chang Ho; Chung-May Yang; Chang-Hao Yang
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

9.  REAL-WORLD EFFECTIVENESS AND SAFETY OF RANIBIZUMAB TREATMENT IN PATIENTS WITH AND WITHOUT POLYPOIDAL CHOROIDAL VASCULOPATHY: Twelve-Month Results From the LUMINOUS Study.

Authors:  Adrian Koh; Timothy Y Y Lai; Wen Bin Wei; Ryusaburo Mori; Harumi Wakiyama; Kyu Hyung Park; Fariza Ngah; Wayne Macfadden; Cornelia Dunger-Baldauf; Soumil Parikh
Journal:  Retina       Date:  2020-08       Impact factor: 3.975

Review 10.  Current management strategy of polypoidal choroidal vasculopathy.

Authors:  Christine P S Ho; Timothy Y Y Lai
Journal:  Indian J Ophthalmol       Date:  2018-12       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.